Boston Scientific has launched a new family of Incepta and Energen implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).
The company said it is also offering an extended warranty of the devices up to 10 years, depending on model, in the US and many other international countries.
Boston Scientific president Mike Mahoney said longer-lasting devices benefit those who are living longer due to advances in device therapy, those who are receiving devices earlier in their lives and those who need more frequent device changes because of their clinical condition.
"We are now backing this longevity with the longest warranty in the industry to support these next-generation devices designed to save and enhance the lives of patients experiencing heart failure and sudden cardiac death," Mahoney said.